Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros [...]
Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros [...]
Mirati Therapeutics, in collaboration with additional groups including Monoceros Biosystems, [...]
Monoceros Biosystems has been selected as a top 10 bioinformatics [...]
Monoceros Biosystems LLC is pleased to announce that John Lamb, [...]